Moody's withdraws Celgene's ratings
For the full text of this story please click the following link: http://www.moodys.com/page/viewresearchdoc.aspx?docid=PR_419719&WT.mc_id=AM~UmV1dGVyc05ld3NfQU1QU19TQl9OUl9DVl9SYXRpbmdfTmV3c19BbGw=~20200313_PR_419719
Recent news on Bristol-Myers Squibb
See all newsPfizer's bowel disease drug succeeds in second late-stage study
Brief: Australia's ACCC Says Not Satisfied Of Claimed Benefits From Proposed Settlement Between Pharmaceutical Cos
Brief: Exscientia Files For U.S. IPO
Brief: Fate Therapeutics Appoints Edward Dulac As Chief Financial Officer
NYSE RESUMED BRISTL MYR SQ RT